View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
September 12, 2011

Jan Medical enrols first patient in cerebral vasospasm study

Jan Medical has enrolled its first patient in a clinical study of the company's portable, continuous brain-sensing system to detect cerebral vasospasm. The study, to be conducted at the University of California, San Francisco, US, is designed to evaluate the Nautilus NeuroWave system's

By cms admin

Jan Medical has enrolled its first patient in a clinical study of the company’s portable, continuous brain-sensing system to detect cerebral vasospasm.

The study, to be conducted at the University of California, San Francisco, US, is designed to evaluate the Nautilus NeuroWave system’s ability to detect vasospasms.

Approximately 70 patients who have survived a subarachnoid haemorrhage stroke will be enrolled in the study.

Jan Medical CEO Paul Lovoi said the Nautilus NeuroWave system can provide critical information on a patient presenting with stroke symptoms, and can also be used as a continuous monitor of changes to the cerebral vasculature.

“We are hopeful that this study will confirm our portable and continuous brain-sensing system’s ability to detect vasospasms quickly and noninvasively,” Lovoi said.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management